Charles Schwab Investment Management Inc Aquestive Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 210,669 shares of AQST stock, worth $623,580. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210,669
Previous 203,540
3.5%
Holding current value
$623,580
Previous $1.01 Million
26.46%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AQST
# of Institutions
124Shares Held
47MCall Options Held
517KPut Options Held
207K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$29 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$16.4 Million2.87% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$12.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$8.19 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $158M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...